Description
BSE announces listing of 1000 bonus equity shares of Ipca Laboratories Ltd kept in abeyance, effective September 1, 2025.
Summary
BSE has announced the listing of 1000 bonus equity shares of Ipca Laboratories Ltd (Scrip Code: 524494) that were previously kept in abeyance. These shares will be available for trading from September 1, 2025.
Key Points
- 1000 bonus equity shares of Rs. 1/- each being listed
- Shares were previously kept in abeyance
- ISIN: INE571A01038
- Distinctive numbers: 1171453 to 1172452
- Trading permitted from Monday, September 1, 2025
Regulatory Changes
No regulatory changes - standard listing procedure for bonus shares released from abeyance.
Compliance Requirements
Trading members are informed of the new securities available for trading.
Important Dates
- Effective Date: September 1, 2025 (Monday)
- Notice Date: August 29, 2025
Impact Assessment
Minimal market impact as this involves a small number of shares (1000) for one company. The release from abeyance is a routine administrative action that makes previously allocated bonus shares available for trading.
Impact Justification
Small number of bonus shares being released from abeyance for single company